Delivery Order SPE2DB22D9206-SPE2DB25FV5CD

Award Date 2/20/25
Potential Completion Date 2/21/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,934.05 Firm Fixed Price delivery order contract is for the provision of XTANDI 40 MG CAPSULE 120S to support the recurring medical supply needs of military health facilities. This award is under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which...
This federal contract award was granted by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,245.40 firm fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,934.05 firm fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, with a performance period ending on July 19, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program,...
This federal contract award, valued at $43,113.50, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,868.10 firm-fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product, with a performance period through August 12, 2024. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $12,934.05, for the provision of XTANDI 40 MG CAPSULE 120S. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $34,572.00 firm fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,934.05 firm fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, a specialty pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,245.40 firm fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which covers a wide range of branded and generic...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a firm fixed-price delivery order valued at $8,622.72, is for the supply of XTANDI 40 MG CAPSULE 120S to support the recurring medical needs of military healthcare facilities worldwide. The contract is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that...
  • SPE2DB22D9206
    Indefinite Delivery Contract
  • SPE2DB22D9206-SPE2DB25FV5CD
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,934.05 firm fixed-price delivery order is for the supply of XTANDI 40 MG CAPSULE 120S, a pharmaceutical product. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 5/22/25, 8:17 PM